Acute Intermittent Porphyria (HMBS) - Gene Analysis
Acute Intermittent Porphyria (HMBS ) Gene Panel by NGS, EDTA Blood** Price
Acute Intermittent Porphyria (HMBS) - Gene Analysis Overview
Acute intermittent porphyria HMBS gene analysis is a genetic test that examines the hydroxymethylbilane synthase (HMBS) gene to identify mutations responsible for causing acute intermittent porphyria (AIP). AIP is an autosomal dominant genetic disorder characterised by a partial deficiency of the HMBS enzyme, which plays a crucial role in the heme biosynthesis pathway. The HMBS gene, located on chromosome 11q23.3, consists of 14 exons and encodes 361 amino acids.
Mutations in the HMBS gene lead to the accumulation of heme precursors such as δ-aminolevulinic acid (δ-ALA) and porphobilinogen (PBG), resulting in various clinical symptoms associated with AIP.
The acute intermittent porphyria HMBS gene analysis is essential for confirming the diagnosis of AIP, identifying carriers within families, and guiding genetic counselling and management strategies for individuals affected by this disorder.
Your body produces a chemical called HMBS, crucial for normal cell function. Mutations in the HMBS gene can lead to Acute Intermittent Porphyria (AIP). This condition disrupts haemoglobin production, causing a build-up of porphyrins. Porphyrins are essential for haemoglobin synthesis and play a role in oxygen transport.
Frequently asked questions
Find quick answers to the most common questions about health tests, bookings, and reports.
Regular exercise, a balanced diet, avoiding smoking, maintaining a healthy weight, and managing stress all help reduce heart disease risk.
Common signs include irritability, trouble sleeping, headaches, difficulty concentrating, and muscle tension.
Ratings & Reviews
We're satisfying our customers every day since 1980.
Choose precision On time, every time!
- 98% on time collections with a 60 minutes promise
- Real-time tracking of phlebotomist arrival and report generation
- Fully digital report delivery—view from mobile or desktop instantly
- Continuous monitoring of turnaround times to ensure accuracy and speed
- Dedicated support team to resolve any delays or queries quickly
Why Metropolis Healthcare?
Metropolis has been present for over 40 years in the market.
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
0
Years of experience
170+
Advanced Labs
Trusted by
Leading Doctors & Hospitals
2,000+
Scientific Officers
Proficiency Testing
for Accurate Reports
Latest Blogs & News
Stay informed with our expert insights and updates.
About Us
Metropolis Healthcare is a leading diagnostic service provider in India. We are a team of dedicated professionals committed to ensuring you and your family receive the most accurate and timely healthcare solutions. We believe in making health care accessible, affordable and evidence-based. Our expert panel are equipped with the latest technology and manned by a certified team of over 4000+ technicians.
In diagnostic services, we have more than three decades of experience servicing diverse stakeholders health advantage packages for men, women and seniors, genetic fitness & corporation in over 650+ tests like Oncology, Neurology, Gynaecology, Haematology, and many more. Our diagnostic services are located in leading doctors and clinics and serve over 15+ cities in India.